Stay updated with breaking news from Bausch amp lomb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dry eye disease drug Xiidra is the centerpiece of the Bausch + Lomb acquisition. The deal with Novartis also includes two experimental products, one for eye pain and the other a medical device for delivering medicines to the eye. ....
Bausch + Lomb drug Miebo is now FDA approved as a new treatment for dry eye disease. Unlike many products that rewet the eye, Miebo is designed to address one of the factors that leads to dry eyes. ....
Alerting students to such job opportunities was the goal of the first ever ROC With Your Hands Career Exploration event last week at the Rochester Community Sports Complex.October 13, 2022 ....
Summer weather is heating up but the market for IPOs remains cold. Bausch + Lomb’s successful return to the public markets in the second quarter proved to be an exception as the slowdown in IPO activity reached levels not seen in years. ....